Inspire Investing LLC grew its holdings in shares of Agilon Health, Inc. (NYSE:AGL – Free Report) by 112.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 166,741 shares of the company’s stock after purchasing an additional 88,411 shares during the quarter. Inspire Investing LLC’s holdings in Agilon Health were worth $384,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. SG Americas Securities LLC increased its position in shares of Agilon Health by 1,271.3% during the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company’s stock valued at $624,000 after purchasing an additional 133,674 shares during the last quarter. Amundi increased its position in shares of Agilon Health by 49.2% during the 1st quarter. Amundi now owns 1,484,709 shares of the company’s stock valued at $5,939,000 after purchasing an additional 489,414 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Agilon Health by 21.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company’s stock valued at $432,000 after purchasing an additional 17,866 shares during the last quarter. Caxton Associates LLP purchased a new stake in shares of Agilon Health during the 1st quarter valued at $1,529,000. Finally, Nisa Investment Advisors LLC increased its position in shares of Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after purchasing an additional 6,783 shares during the last quarter.
Agilon Health Stock Down 5.6%
Shares of NYSE AGL opened at $0.96 on Friday. Agilon Health, Inc. has a 52 week low of $0.71 and a 52 week high of $6.08. The business has a 50-day simple moving average of $1.12 and a two-hundred day simple moving average of $2.28. The company has a market cap of $399.00 million, a P/E ratio of -1.25 and a beta of 0.07.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on AGL shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Robert W. Baird decreased their target price on Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a research report on Thursday, August 14th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $1.40 target price (down from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Evercore ISI decreased their price objective on Agilon Health from $5.00 to $3.00 and set an “in-line” rating for the company in a report on Wednesday, July 9th. Finally, Benchmark decreased their price objective on Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a report on Wednesday, August 6th. Four equities research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Agilon Health currently has a consensus rating of “Hold” and an average price target of $2.81.
Get Our Latest Analysis on Agilon Health
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than Agilon Health
- Conference Calls and Individual Investors
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- There Are Different Types of Stock To Invest In
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilon Health, Inc. (NYSE:AGL – Free Report).
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.